Monosomy 22 in a fibrothecoma.

We found a 45,XX, -22 karyotype as the sole chromosome change in a fibrothecoma of a 67-year-old woman. These cytogenetic findings are discussed in the light of relevant cytogenetic and pathology literature data on ovarian sex cord tumors.

Oral glucose tolerance test is a poor predictor of hyperglycemia during pregnancy.

In an effort to assess the efficacy of the oral glucose tolerance test to detect patients with gestational diabetes mellitus who require therapeutic measures to maintain normoglycemia, we compared the results of an oral glucose tolerance test with those of a home glucose profile consisting of three postprandial glucose values in 250 pregnant women. The OGTT overestimated the occurrence of hyperglycemia by 28%, while the home glucose profile underestimated the occurrence of hyperglycemia by 5%. Pregnancy outcome was not significantly different between spontaneously normoglycemic women and those who required therapy. One cannot effectively identify the ten percent largest infants in the population by screening for gestational diabetes.

Effects of injection volume on the tissue dose, dose rate, and therapeutic potential intraperitoneal 32p.

Increasing the injection volume had no significant long-term effect on the distribution or tissue dose of intraperitoneal 32P in New Zealand white rabbits. Further, the range of doses and dose rates observed in the rabbit had little effect in vitro against either a human ovarian cancer line or an established Chinese hamster cell line. Demonstrable kill of human ovarian cancer cells was achieved, however, for initial 32P dose rates of 11 and 22 rad/h (0.11 and 0.22 Gy/h). From these results, it is estimated that administered 32P activities ranging from about 75-150 mCi (2.8-5.6 GBq) would be required for significant tumoricidal effects in ovarian cancer patients.